Business
Halberd Corporation Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX(TM) Immune Booster
Halberd Corporation Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX(TM) Immune Booster.
About this update from Halberd Corp.
[{"type":"text","content":"JACKSON CENTER, PA / ACCESSWIRE / March 23, 2021 / Halberd Corporation (OTC PINK:HALB) has compiled a number of third party published articles from various medical publications which support the selection of the various nutraceuticals in Halberd's VITA-SHIELD-MAXTM Immune Booster.William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, "After reviewing numerous peer reviewed articles from various publications, the Halberd team reached a consensus on which nutraceuticals (vitamins and minerals) to include in our Immunity Booster to provide the most benefit. These articles indicate the benefits each of our ingredients have on maintaining the health and well-being of individuals. We intend to make this document available to our sales personnel, government agencies, medical care facilities, etc. to raise awareness of our VITA-SHIELD-MAXTM Immune Booster."Click here to view the compilation.To get the latest news on Halberd's exciting developments, subscribe by submitting this form.(https://halberdcorporation.com/contact-us/)For more information please contact:William A. [email protected]@halberdcorporation.comwww.halberdcorporation.comTwitter:@HalberdCAbout Halberd Corporation.Halberd Corporation (OTC-PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. It is debt-free and holds the exclusive rights to several patent pending COVID-19 extracorporeal treatments:Title Patent/Application No. Filing DateStatus/Document*Method for Treating and CuringCovid-19 InfectionUS 62/98998103/16/2020Provisionalprovisional_COVID-19_kk,4823-1130-2071.docxPCT/US21/2254103/16/2021International PCT995-004PCT-Application-FINAL.pdf*Method for Treating Covid-19Inflammatory Cytokine Storm for theReduction of Morbidity and Mortality inCovid-19 PatientsUS 63/00720704/08/2020ProvisionalCytokine-provisional-kk,4826-5866-1817.docx*Method for Treating and Curing Covid-19Infection by Utilizing a Laser to Eradicatethe VirusUS 63/01310404/21/2020ProvisionalLaser Method forTreating and CuringCovid,4834-1487-7370.docx*Method For The Rapid Identification OfCovid-19 InfectionUS 63/04944107/08/2020ProvisionalRapid Covid detection.pdf*Nasal Spray To Prevent The TransmissionOf Covid-19 Between HumansUS 63/08073509/20/2020Provisional...